Revenue Recognition (Details)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Disaggregation of Revenue [Line Items]
Percentage of net sales	100.00%	100.00%
Revenue Benchmark [Member] | Product Concentration Risk [Member] | High-Value Components [Member]
Disaggregation of Revenue [Line Items]
Percentage of net sales	43.00%	43.00%
Revenue Benchmark [Member] | Product Concentration Risk [Member] | Standard Packaging [Member]
Disaggregation of Revenue [Line Items]
Percentage of net sales	28.00%	30.00%
Revenue Benchmark [Member] | Product Concentration Risk [Member] | Delivery Devices [Member]
Disaggregation of Revenue [Line Items]
Percentage of net sales	5.00%	4.00%
Revenue Benchmark [Member] | Product Concentration Risk [Member] | Contract-Manufactured Products [Member]
Disaggregation of Revenue [Line Items]
Percentage of net sales	24.00%	23.00%
Biologics [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Percentage of net sales	28.00%	26.00%
Generics [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Percentage of net sales	19.00%	20.00%
Pharma [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Percentage of net sales	29.00%	31.00%
Contract-Manufactured Products [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Percentage of net sales	24.00%	23.00%
Americas [Member] | Revenue Benchmark [Member] | Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Percentage of net sales	48.00%	46.00%
Europe, Middle East, Africa [Member] | Revenue Benchmark [Member] | Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Percentage of net sales	44.00%	47.00%
Asia Pacific [Member] | Revenue Benchmark [Member] | Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Percentage of net sales	8.00%	7.00%